The Fort Worth Press - Formerra to Supply Foster Medical Compounds in Europe

USD -
AED 3.672505
AFN 64.999617
ALL 81.873378
AMD 378.439629
ANG 1.79008
AOA 917.000017
ARS 1444.993898
AUD 1.424623
AWG 1.8025
AZN 1.698328
BAM 1.658498
BBD 2.01317
BDT 122.152876
BGN 1.67937
BHD 0.37697
BIF 2962.5
BMD 1
BND 1.270543
BOB 6.906845
BRL 5.239098
BSD 0.999546
BTN 90.307481
BWP 13.806116
BYN 2.86383
BYR 19600
BZD 2.010235
CAD 1.36445
CDF 2199.999975
CHF 0.776105
CLF 0.021794
CLP 860.539972
CNY 6.938197
CNH 6.93502
COP 3646.93
CRC 496.408795
CUC 1
CUP 26.5
CVE 93.750278
CZK 20.60345
DJF 177.720253
DKK 6.32319
DOP 63.000254
DZD 129.900254
EGP 47.009197
ERN 15
ETB 155.042675
EUR 0.846625
FJD 2.198801
FKP 0.732491
GBP 0.730199
GEL 2.695012
GGP 0.732491
GHS 10.944975
GIP 0.732491
GMD 73.000094
GNF 8753.999774
GTQ 7.666672
GYD 209.120397
HKD 7.813115
HNL 26.408086
HRK 6.376701
HTG 131.107644
HUF 322.478502
IDR 16766
ILS 3.082015
IMP 0.732491
INR 90.36925
IQD 1309.380459
IRR 42125.000158
ISK 122.749952
JEP 0.732491
JMD 156.640605
JOD 0.709028
JPY 155.879497
KES 129.000415
KGS 87.449822
KHR 4081.504905
KMF 417.999853
KPW 899.987247
KRW 1450.779878
KWD 0.30715
KYD 0.83298
KZT 501.119346
LAK 21499.832523
LBP 89508.041026
LKR 309.380459
LRD 185.911623
LSL 16.009531
LTL 2.95274
LVL 0.60489
LYD 6.319217
MAD 9.168716
MDL 16.926717
MGA 4429.877932
MKD 52.189044
MMK 2100.119929
MNT 3568.429082
MOP 8.04357
MRU 39.901294
MUR 45.890045
MVR 15.450054
MWK 1733.257012
MXN 17.245898
MYR 3.932499
MZN 63.750319
NAD 16.009531
NGN 1391.85959
NIO 36.785781
NOK 9.627875
NPR 144.492309
NZD 1.656195
OMR 0.384498
PAB 0.999521
PEN 3.364907
PGK 4.282347
PHP 59.040236
PKR 279.545138
PLN 3.57644
PYG 6631.277242
QAR 3.634567
RON 4.313702
RSD 99.384049
RUB 76.999691
RWF 1458.783824
SAR 3.750106
SBD 8.058101
SCR 13.748799
SDG 601.49205
SEK 8.90851
SGD 1.270205
SHP 0.750259
SLE 24.475005
SLL 20969.499267
SOS 570.272883
SRD 38.114499
STD 20697.981008
STN 20.775741
SVC 8.746163
SYP 11059.574895
SZL 16.015332
THB 31.639928
TJS 9.340767
TMT 3.51
TND 2.890372
TOP 2.40776
TRY 43.496603
TTD 6.770319
TWD 31.588801
TZS 2584.040204
UAH 43.256279
UGX 3563.251531
UYU 38.49872
UZS 12236.487289
VES 371.640565
VND 26002
VUV 119.537583
WST 2.726316
XAF 556.244594
XAG 0.011767
XAU 0.000201
XCD 2.70255
XCG 1.801384
XDR 0.691072
XOF 556.244594
XPF 101.131218
YER 238.374992
ZAR 15.96902
ZMK 9001.202602
ZMW 19.615608
ZWL 321.999592
  • RBGPF

    0.1000

    82.5

    +0.12%

  • VOD

    0.3400

    15.25

    +2.23%

  • BTI

    0.8800

    61.87

    +1.42%

  • BP

    1.1200

    38.82

    +2.89%

  • RYCEF

    0.2800

    16.95

    +1.65%

  • GSK

    0.8700

    53.34

    +1.63%

  • CMSC

    -0.0900

    23.66

    -0.38%

  • AZN

    -4.0900

    184.32

    -2.22%

  • SCS

    0.0200

    16.14

    +0.12%

  • NGG

    1.6200

    86.23

    +1.88%

  • RIO

    3.8500

    96.37

    +4%

  • RELX

    -5.0200

    30.51

    -16.45%

  • CMSD

    -0.1400

    23.94

    -0.58%

  • JRI

    -0.0300

    13.12

    -0.23%

  • BCC

    3.1800

    84.93

    +3.74%

  • BCE

    0.2700

    26.1

    +1.03%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

B.Martinez--TFWP